Clinical Trial Update: Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and immunogenicity of the MVA85A tuberculosis vaccine and its impact on the immunogenicity of Expanded Program on Immunizati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• MVA85A TB vaccine (MVA85A)

Snippet

Sponsor: University of Oxford | Conditions: TB | Phase 1 | Status: COMPLETED